Top Markets
#1 Siren Siren +33.90%
#2 Wiki Cat Wiki Cat +25.38%
#3 TRIA TRIA +20.37%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.09%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +15.56%
#7 Bitway Bitway +15.11%
#8 Nockchain Nockchain +14.64%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.63%
#10 KUB Coin KUB Coin +14.59%
Coin of the day
Siren Siren
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Clasificación en acciones #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Precio por acción
$0.089
Última sincronización: 2026-08-17
Capitalización bursátil
$15.36M
Cambio (1 día)
50.59%
Cambio (1 año)
111.85%
País
US
Comercio Inhibitor Therapeutics, Inc. (INTI)

Categoría

Healthcare
Historial del precio de la acción de Inhibitor Therapeutics, Inc. (INTI)
Precio más alto de cierre: $0.08 el 2026-08-01

Precio más bajo de cierre: $13.64 el 2003-09-01
Historial del precio de la acción de Inhibitor Therapeutics, Inc. desde 2003 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 36.71%
2025 -32.43%
2024 -25.17%
2023 28.96%
2022 -48.45%
2021 273.68%
2020 -20.00%
2019 -55.15%
2018 -60.33%
2017 -30.61%
2016 198.81%
2015 -0.18%
2014 51.76%
2013 -99.13%
2004 -21.95%
2003 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 50.70%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.31 -36.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.87%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 13.01%
BE